OPKO Health’s (OPK) Outperform Rating Reiterated at Barrington Research
Barrington Research reissued their outperform rating on shares of OPKO Health (NASDAQ:OPK – Free Report) in a research report released on Thursday morning,Benzinga reports. They currently have a $2.25 target price on the biotechnology company’s stock. A number of other research firms have also weighed in on OPK. HC Wainwright reiterated a “buy” rating and […]
Barrington Research reissued their outperform rating on shares of OPKO Health (NASDAQ:OPK – Free Report) in a research report released on Thursday morning,Benzinga reports. They currently have a $2.25 target price on the biotechnology company’s stock. A number of other research firms have also weighed in on OPK. HC Wainwright reiterated a “buy” rating and […]
